Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: 023910)
South Korea flag South Korea · Delayed Price · Currency is KRW
26,850
0.00 (0.00%)
Dec 20, 2024, 9:00 AM KST

Daihan Pharmaceutical Co.,Ltd. Revenue

Daihan Pharmaceutical Co.,Ltd. had revenue of 54.85B KRW in the quarter ending September 30, 2024, with 7.70% growth. This brings the company's revenue in the last twelve months to 201.97B, up 3.83% year-over-year. In the year 2023, Daihan Pharmaceutical Co.,Ltd. had annual revenue of 195.91B with 6.32% growth.

Revenue (ttm)
201.97B
Revenue Growth
+3.83%
P/S Ratio
0.78
Revenue / Employee
365.23M
Employees
553
Market Cap
157.88B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023195.91B11.64B6.32%
Dec 31, 2022184.27B12.80B7.47%
Dec 31, 2021171.46B5.38B3.24%
Dec 31, 2020166.08B-2.68B-1.59%
Dec 31, 2019168.76B10.04B6.33%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition